These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Lung clearance index response in patients with CF with class III CFTR mutations. Kane M; Gonska T; Jensen R; Avolio J; Klingel M; Stanojevic S; Ratjen F Thorax; 2016 May; 71(5):476-7. PubMed ID: 26944510 [No Abstract] [Full Text] [Related]
14. Lumacaftor/ivacaftor for patients homozygous for Phe508del-CFTR: should we curb our enthusiasm? Jones AM; Barry PJ Thorax; 2015 Jul; 70(7):615-6. PubMed ID: 26071414 [No Abstract] [Full Text] [Related]
19. Therapy for cystic fibrosis--the end of the beginning? Davis PB N Engl J Med; 2011 Nov; 365(18):1734-5. PubMed ID: 22047565 [No Abstract] [Full Text] [Related]
20. Ivacaftor and Airway Inflammation in Preschool Children with Cystic Fibrosis. McNally P; Butler D; Karpievitch YV; Linnane B; Ranganathan S; Stick SM; Hall GL; Schultz A Am J Respir Crit Care Med; 2021 Sep; 204(5):605-608. PubMed ID: 34077699 [No Abstract] [Full Text] [Related] [Next] [New Search]